Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era

By sjmartinez • May 20, 2025

Pohlman N, Patel PN, Essien UR, Tang JJ, Joseph JJ. Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era. J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210/clinem/dgaf295. Epub ahead of print. PMID: 40388382.

Tags: cardiovascular disease, cardiovascular-kidney-metabolic syndrome, General Internal Medicine, Kidney disease, Obesity, Publications, Type 2 diabetes mellitus, Veterans Administration

Effects Of Medicare Advantage On Health Care Use And Outcomes Among Retired State Employees In 5 States

Huckfeldt PJ, Boese T, Shier V, Escarce JJ, Parsons HM, Sood N. Effects Of Medicare Advantage On Health Care Use And Outcomes Among Retired State[...]

Racial Differences in the Association Between School Quality and Adult Health: A Nationally Representative Longitudinal Study

Meza BPL, Hoang K, Biely C, Jackson N, Leifheit KM, Barnert E, Schickedanz A, Khidir H, Iyer S, Slavich GM, Guerrero AD, Dudovitz RN. Racial[...]

Implications of High Prevalence of Social Risks in a Veteran Population: The Importance of Actionable Social Risk Screening

Orji WU, Smith PD, Elmore JG. Implications of High Prevalence of Social Risks in a Veteran Population: The Importance of Actionable Social Risk Screening. J[...]